Myoepithelioma of bone with a novel FUS-POU5F1 fusion gene

Histopathology

Volumn 65, Issue 6, 2014, Pages 917-922

  Puls, Florian ^a   Arbajian, Elsa ^b   Magnusson, Linda ^b   Douis, Hassan ^a   Kindblom, Lars Gunnar ^a,c   Mertens, Fredrik ^b  

^a ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Fluorescence in situ hybridisation; Myoepithelial tumour; Myoepithelioma; Reverse transcriptase polymerase chain reaction

Indexed keywords

CYTOKERATIN; DESMIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; MUCIN 4; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P63; PROTEIN S 100; SMOOTH MUSCLE ACTIN; ONCOPROTEIN; POU5F1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADULT; ARTICLE; BONE TUMOR; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME G BAND; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EWSR1 GENE; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; FUS POU5F1 GENE; FUSION GENE; GENE; HUMAN; HUMAN TISSUE; LOW BACK PAIN; MALE; METASTASIS; MIDDLE AGED; MYOEPITHELIOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACRUM; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS;

BONE NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MYOEPITHELIOMA; OCTAMER TRANSCRIPTION FACTOR-3; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEIN FUS;

EID: 84916617897     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12517     Document Type: Article

References (27)

1. Kilpatrick SE, Hitchcock MG, Kraus MD, Calonje E, Fletcher CDM. Mixed tumors and myoepitheliomas of soft tissue: a clinicopathologic study of 19 cases with a unifying concept. Am. J. Surg. Pathol. 1997; 21; 13-22.
2. Fletcher CDM, Antonescu CR, Heim S, Hornick JL. Myoepithelioma/myoepithelial carcinoma/mixed tumour. In Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F eds. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France: IARC Press, 2013; 208-209.
3. Antonescu CR, Zhang L, Chang N-E et al. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosom. Cancer 2010; 49; 1114-1124.
4. Rekhi B, Sable M, Jambhekar NA. Histopathological, immunohistochemical and molecular spectrum of myoepithelial tumours of soft tissues. Virchows Arch. 2012; 461; 687-697.
5. Gleason BC, Fletcher CDM. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am. J. Surg. Pathol. 2007; 31; 1813-1824.
6. Hornick JL, Fletcher CDM. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am. J. Surg. Pathol. 2003; 27; 1183-1196.
7. Flucke U, Mentzel T, Verdijk MA et al. EWSR1-ATF1 chimeric transcript in a myoepithelial tumor of soft tissue: a case report. Hum. Pathol. 2012; 43; 764-768.
8. Kurzawa P, Kattapuram S, Hornicek FJ, Antonescu CR, Rosenberg AE, Nielsen GP. Primary myoepithelioma of bone: a report of 8 cases. Am. J. Surg. Pathol. 2013; 37; 960-968.
9. Romeo S, Bovée JVMG, Kroon HM et al. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch. 2012; 461; 561-570.
10. Franchi A, Palomba A, Roselli G et al. Primary juxtacortical myoepithelioma/mixed tumor of the bone: a report of 3 cases with clinicopathologic, immunohistochemical, ultrastructural, and molecular characterization. Hum. Pathol. 2013; 44; 566-577.
11. Mandahl N. Methods in solid tumor cytogenetics. In Rooney DE ed. Human cytogenetics: malignancy and acquired abnormalities. New York: Oxford University Press, 2001; 165-203.
12. Jin Y, Möller E, Nord KH et al. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes. Genes Chromosom. Cancer 2012; 51; 510-520.
13. Riggi N, Cironi L, Suva ML, Stamenkovic I. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J. Pathol. 2007; 213; 4-20.
14. Jerabek S, Merino F, Schöler HR, Cojocaru V. OCT4: dynamic DNA binding pioneers stem cell pluripotency. Biochim. Biophys. Acta 2014; 1839; 138-154.
15. Wang X, Dai J. Isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells 2010; 28; 885-893.
16. Morohoshi F, Ootsuka Y, Arai K et al. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. Gene 1998; 221; 191-198.
17. Ryan AK, Rosenfeld MG. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev. 1997; 11; 1207-1225.
18. Möller E, Stenman G, Mandahl N et al. POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J. Pathol. 2008; 215; 78-86.
19. Yamaguchi S, Yamazaki Y, Ishikawa Y, Kawaguchi N, Mukai H, Nakamura T. EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Genes Chromosom. Cancer 2005; 43; 217-222.
20. Deng FM, Galvan K, de la Roza G, Zhang S, Souid AK, Stein CK. Molecular characterization of an EWSR1-POU5F1 fusion associated with a t(6;22) in an undifferentiated soft tissue sarcoma. Cancer Genet. 2011; 204; 423-429.
21. Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am. J. Surg. Pathol. 2013; 37; 734-738.
22. Panagopoulos I, Höglund M, Mertens F, Mandahl N, Mitelman F, Aman P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996; 12; 489-494.
23. Hallor KH, Mertens F, Jin Y et al. Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosom. Cancer 2005; 44; 97-102.
24. Arbajian E, Puls F, Magnusson L et al. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am. J. Surg. Pathol. 2014; 38; 801-808.
25. Zinszner H, Albalat R, Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 1994; 8; 2513-2526.
26. Demicco EG, Wang WL, Madewell JE et al. Osseous myxochondroid sarcoma: a detailed study of 5 cases of extraskeletal myxoid chondrosarcoma of the bone. Am. J. Surg. Pathol. 2013; 37; 752-762.
27. Doyle LA, Wang WL, Dal Cin P et al. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am. J. Surg. Pathol. 2012; 36; 1444-1451.